CytoAgents
Pittsburgh, PA
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation also known as cytokine storm.
cytoagents.comCompany Details
Founded
- 2018
Employees
- Between 5 - 20 employees
Raised
- $17,206,500
Headquarters Location
- Pittsburgh, PA
Public
- No
Acquired
- No
CEO
Teresa Whalen
Founders
- Teresa Whalen
Company Collections
These are collections CytoAgents is a part of. Click on the collection name to view similar companies.